Bupropion morpholinol-d6

• UNSPSC Description:

  Bupropion morpholinol-d6 is the deuterated form of Bupropion morpholinol. Bupropion morpholinol is a major metabolite of Bupropion. Bupropion morpholinol inhibits Dopamine, Norepinephrine transporters and the α4β2 nicotinic receptor in vitro. Bupropion morpholinol contributes to antidepressant and smoking cessation activities[1].

• Target Antigen:

  Dopamine Transporter; Isotope-Labeled Compounds; nAChR

• Type:

  Isotope-Labeled Compounds

• Related Pathways:

  Membrane Transporter/Ion Channel;Neuronal Signaling;Others

• Field of Research:

  Neurological Disease

• Purity:

  99.28

• Solubility:

  10 mM in DMSO

• Smiles:

  OC1(C2=CC=CC(Cl)=C2)C(C)NC(C([2H])([2H])[2H])(C([2H])([2H])[2H])CO1

• Molecular Weight:

  261.78

• References & Citations:

  [1]Zhu A Z X, et al. CYP2B6 and bupropion's smoking‐cessation pharmacology: the role of hydroxybupropion[J]. Clinical Pharmacology & Therapeutics, 2012, 92(6): 771-777.

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  -20°C, 3 years (Powder)

• Clinical Information:

  No Development Reported

• CAS Number:

  1216893-18-3